lobbying_activities: 2637553
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2637553 | 31326ac8-1646-4210-8600-6f1064482272 | Q2 | RUBICON ADVISORS, LLC | 315091 | DYNAVAX TECHNOLOGIES | 2021 | second_quarter | PHA | Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA) | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2021-07-15T09:37:00.263000-04:00 |